Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases (vol 80, pg 99, 2020)Gastroenterology Unit, Clinical University Hospital Lozano Bless IIS Aragón, Zaragoza, Spain.
Centre for Gastroenterology, Royal Free Hospital, London, UK.
IBD Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UK.
Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Gastroenterology, McGill University, Montreal QC, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
Department of Pharmaceutical Engineering, College of Life and Health Science, Hoseo University, Asan, Republic of Korea.
Cyprus League Against Rheumatism, Nicosia, Cyprus.
Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK; Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Inflammatory Bowel Disease Unit, Nancy University Hospital, Allée du Morvan, France.
Department Medicine I, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Skeletal Biology and Engineering Research Center KU Leuven, Rheumatology University Hospital Leuven, Leuven, Belgium.
Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, IRCCS, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
Show others and affiliations
2020 (English)In: Drugs, ISSN 0012-6667, E-ISSN 1179-1950, Vol. 80, no 10, p. 1039-1040Article in journal (Refereed) Published
Abstract [en]
The affiliation of the corresponding author Silvio Danese, which currently reads.
Place, publisher, year, edition, pages
Adis International , 2020. Vol. 80, no 10, p. 1039-1040
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:oru:diva-83242DOI: 10.1007/s40265-020-01333-9ISI: 000537350300001PubMedID: 32488813Scopus ID: 2-s2.0-85086677992OAI: oai:DiVA.org:oru-83242DiVA, id: diva2:1441648
2020-06-162020-06-162020-12-10Bibliographically approved